AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED LIMITED PARTNERSHIP AGREEMENT FOR A LIMITED PARTNERSHIP CALLED PROKIDNEY LPLimited Partnership Agreement • March 22nd, 2024 • Prokidney Corp. • Biological products, (no disgnostic substances)
THIS AMENDMENT NO. 1 TO THE SECOND AMENDED AND RESTATED LIMITED PARTNERSHIP AGREEMENT FOR A LIMITED PARTNERSHIP CALLED PROKIDNEY LP (this “Amendment”) is made and entered into as of Nov. 14 2023 by ProKidney Corp. GP Limited (the “General Partner”), in its capacity as sole general partner of the Partnership (as defined below) and as the duly appointed attorney of the other partners in the Partnership (other than ProKidney Corp. (f/k/a Social Capital Suvretta Holdings Corp. III) (“PubCo”)), and PubCo. Capitalized terms used herein without definition have the meanings ascribed to such terms in the Second A&R Partnership Agreement (as defined below).
